You are here


Found 85 results

Sort by:[Year][Author]
Filters: keyword is Animals  [Clear All Filters]
2007
GoeminneA, McNaughtonM, BalG, SurpateanuG, VanDerV, DeProl S, VerseesW, SteyaertJ, ApersS, HaemersA, AugustynsK.  2007.  1,2,3-Triazolylalkylribitol derivatives as nucleoside hydrolase inhibitors. Bioorg. & Med. Chem. Lett.. 17(9):2523-2526. Abstract
AdriaensenC, De GreveH, TianJQ, De CraeyeS, GubbelsE, EeckhautV, Van ImmerseelF, DucatelleR, KumarM, HernalsteensJP.  2007.  A live Salmonella enterica serovar Enteritidis vaccine allows serological differentiation between vaccinated and infected animals. 75(5):2461-2468. Abstract
CandelAM, Conejero-LaraF, MartinezJC, van NulandNA, BruixM.  2007.  The high-resolution NMR structure of a single-chain chimeric protein mimicking a SH3-peptide complex. 581(4):687-692. Abstract
CasaresS, AbE, EshuisH, Lopez-MayorgaO, van NulandNA, Conejero-LaraF.  2007.  The high-resolution NMR structure of the R21A Spc-SH3:P41 complex: understanding the determinants of binding affinity by comparison with Abl-SH3. 7:22. Abstract
De GreveH, WynsL, BouckaertJ.  2007.  Combining sites of bacterial fimbriae. Current opinion in structural biology. 17(5):506-512. Abstract
2006
MessensJ, SilverS.  2006.  Arsenate reduction: thiol cascade chemistry with convergent evolution. J. Mol. Biol.. 362(1):1-17. Abstract
VandemeulebrouckeA, VerseesW, SteyaertJ, BarlowJN.  2006.  Multiple transients in the pre-steady-state of nucleoside hydrolase reveal complex substrate binding, product base release, and two apparent rates of chemistry. Biochemistry. 45(30):9307-9318. Abstract
VerseesW, BarlowJ, SteyaertJ.  2006.  Transition-state complex of the purine-specific nucleoside hydrolase of T. vivax: enzyme conformational changes and implications for catalysis. Journal Molecular Biology. 359(2):331-346. Abstract
DeGenst E, SilenceK, DecanniereK, ConrathK, LorisR, KinneJ, MuyldermansS, WynsL.  2006.  Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies. 103(12):4586-4591. Abstract
MessensJ, ColletJF.  2006.  Pathways of disulfide bond formation in Escherichia coli. Int. J. Biochem. Cell Biol.. 38(7):1050-1062. Abstract
2005
RanquinA, VerseesW, MeierW, SteyaertJ, VanGelder P.  2005.  Therapeutic nanoreactors: combining chemistry and biology in a novel triblock copolymer drug delivery system. Nanoletters. 5(11):2220-2224. Abstract
Garcia-PinoA, LorisR, WynsL, ButsL.  2005.  Crystallization and preliminary X-ray analysis of the Man(alpha1-2)Man-specific lectin from Bowringia mildbraedii in complex with its carbohydrate ligand. 61(Pt 10):931-934. Abstract
SaerensD, PellisM, LorisR, PardonE, DumoulinM, MatagneA, WynsL, MuyldermansS, ConrathK.  2005.  Identification of a universal VHH framework to graft non-canonical antigen-binding loops of camel single-domain antibodies. 352(3):597-607. Abstract
ConrathK, VinckeC, StijlemansB, SchymkowitzJ, DecanniereK, WynsL, MuyldermansS, LorisR.  2005.  Antigen binding and solubility effects upon the veneering of a camel VHH in framework-2 to mimic a VH. 350(1):112-125. Abstract
LoverixS, GeerlingsP, McNaughtonM, AugustynsK, VandemeulebrouckeA, SteyaertJ, VerseesW.  2005.  Substrate-assisted leaving group activation in enzyme-catalyzed N-glycosidic bond cleavage. J. Biol. Chem. 280(15):14799-14802. Abstract
DeGenst E, SilenceK, GhahroudiMA, DecanniereK, LorisR, KinneJ, WynsL, MuyldermansS.  2005.  Strong in vivo maturation compensates for structurally restricted H3 loops in antibody repertoires. 280(14):14114-14121. Abstract
DumoulinM, CanetD, LastAM, PardonE, ArcherDB, MuyldermansS, WynsL, MatagneA, RobinsonCV, RedfieldC, DobsonCM.  2005.  Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations. Nature. 346(3):773-788. Abstract
2004
DeGenst E, HandelbergF, VanMeirhaeghe A, VynckS, LorisR, WynsL, MuyldermansS.  2004.  Chemical basis for the affinity maturation of a camel single domain antibody. 279(51):53593-53601. Abstract
TzakosAG, FuchsP, van NulandNA, TroganisA, TseliosT, DeraosS, MatsoukasJ, GerothanassisIP, BonvinAM.  2004.  NMR and molecular dynamics studies of an autoimmune myelin basic protein peptide and its antagonist: structural implications for the MHC II (I-Au)-peptide complex from docking calculations. 271(16):3399-3413. Abstract
HechtO, van NulandNA, SchleinkoferK, DingleyAJ, BruhnH, LeippeM, GrotzingerJ.  2004.  Solution structure of the pore-forming protein of Entamoeba histolytica. 279(17):17834-17841. Abstract
VerseesW, LoverixS, VandemeulebrouckeA, GeerlingsP, SteyaertJ.  2004.  Leaving group activation by aromatic stacking: an alternative to general acid catalysis. J. Mol. Biol. 338(1):1-6. Abstract
CasaresS, SadqiM, Lopez-MayorgaO, Conejero-LaraF, van NulandNA.  2004.  Detection and characterization of partially unfolded oligomers of the SH3 domain of alpha-spectrin. 86(4):2403-2413. Abstract
StijlemansB, ConrathK, Cortez-RetamozoV, VanXong H, WynsL, SenterP, RevetsH, DeBaetselier P, MuyldermansS, MagezS.  2004.  Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm. 279(2):1256-1261. Abstract
2003
VandemeulebrouckeA, VerseesW, DeVos S, VanHolsbeke E, SteyaertJ.  2003.  Pre-steady-state analysis of the nucleoside hydrolase of Trypanosoma vivax. Evidence for half-of-the-sites reactivity and rate-limiting product release. Biochemistry. 42(44):12902-12908. Abstract
DumoulinM, LastAM, DesmyterA, DecanniereK, CanetD, LarssonG, SpencerA, ArcherDB, SasseJ, MuyldermansS, WynsL, RedfieldC, MatagneA, RobinsonCV, DobsonCM.  2003.  A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme. 424(6950):783-788. Abstract